Cited by — Clinical impact of prospective circulating tumour DNA testing for minimal residual disease in colorectal cancer: the INTERCEPT programme experience | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Clinical impact of prospective circulating tumour DNA testing for minimal residual disease in colorectal cancer: the INTERCEPT programme experience.
No admitted local citation edges point to this work yet.
